DNA within chromatin regulates gene expression, influences cellular responses and is at the heart of cancer genetics and epigenetics. It is essential to understand how DNA and epigenetic alterations contribute to signaling pathways and impact treatment strategies. It also enables genomics to be exploited for precision medicine and biomarker discovery, making it an essential component of global cancer research.

RNA molecules, both coding and non-coding, play an essential role in modulating gene expression and influencing cell signaling pathways. Understanding the complex mechanisms by which RNA participates in cancer-related signaling events is essential to unravel the complexities of the disease. This session will explore emerging areas such as the impact of non-coding RNA on oncogenic pathways, potentially revealing new therapeutic targets and diagnostic markers. In addition, RNA-based technologies and therapies, such as mRNA vaccines, are gaining importance in cancer treatment, making it imperative to keep abreast of these advances as part of the symposium.

Understanding the role of proteins and cellular communications in oncogenic pathways is fundamental to identifying therapeutic targets and biomarkers. In addition, targeted therapies often focus on the inhibition or modulation of specific proteins, making this session an integral part of advancing cancer treatment strategies.